 Source: Roland Magnusson Shutterstock.com LogicBio NASDAQ: LOGC stock is seeing massive gains on Monday following news that AstraZeneca NASDAQ: AZN subsidiary Alexion is acquiring the clinical-stage genetic medicine company. The deal has Alexion agreeing to a cash tender offer for all outstanding shares of LOGC stock. 